Vycor Medical, Inc. (VYCO)
OTCMKTS · Delayed Price · Currency is USD
0.0660
+0.0090 (15.79%)
Jun 17, 2026, 4:00 PM EST
Vycor Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.89 | 1.86 | 1.59 | 1.46 | 1.22 | 1.39 | |
Revenue Growth (YoY) | 11.65% | 17.24% | 8.81% | 19.43% | -12.20% | 21.97% |
Cost of Revenue | 0.31 | 0.3 | 0.17 | 0.14 | 0.14 | 0.13 |
Gross Profit | 1.58 | 1.56 | 1.42 | 1.32 | 1.08 | 1.26 |
Selling, General & Admin | 1.42 | 1.46 | 1.36 | 1.2 | 1.33 | 1.61 |
Research & Development | 0 | 0.01 | 0.02 | 0.02 | - | 0.02 |
Operating Expenses | 1.49 | 1.53 | 1.43 | 1.28 | 1.39 | 1.69 |
Operating Income | 0.09 | 0.03 | -0.01 | 0.04 | -0.31 | -0.44 |
Interest Expense | -0.1 | -0.1 | -0.1 | -0.1 | -0.09 | -0.09 |
Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0 | -0 | -0 |
Other Non Operating Income (Expenses) | - | - | 0.01 | - | - | - |
EBT Excluding Unusual Items | -0.01 | -0.07 | -0.11 | -0.06 | -0.4 | -0.53 |
Other Unusual Items | - | - | - | - | - | 0.12 |
Pretax Income | -0.01 | -0.07 | -0.11 | -0.06 | -0.4 | -0.41 |
Earnings From Continuing Operations | -0.01 | -0.07 | -0.11 | -0.06 | -0.4 | -0.41 |
Earnings From Discontinued Operations | -0 | -0 | -0 | -0.01 | -0.01 | -0.03 |
Net Income | -0.01 | -0.07 | -0.11 | -0.07 | -0.4 | -0.44 |
Preferred Dividends & Other Adjustments | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
Net Income to Common | -0.34 | -0.4 | -0.43 | -0.39 | -0.73 | -0.76 |
Shares Outstanding (Basic) | 33 | 33 | 33 | 33 | 32 | 30 |
Shares Outstanding (Diluted) | 33 | 33 | 33 | 33 | 32 | 30 |
Shares Change (YoY) | 0.91% | 1.48% | 0.86% | 2.83% | 7.02% | 13.51% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 |
Free Cash Flow | 0.11 | -0.02 | 0.05 | 0.02 | -0.22 | -0.02 |
Free Cash Flow Per Share | 0.00 | -0.00 | 0.00 | 0.00 | -0.01 | -0.00 |
Gross Margin | 83.67% | 83.78% | 89.50% | 90.08% | 88.50% | 90.33% |
Operating Margin | 4.91% | 1.82% | -0.57% | 2.75% | -25.06% | -31.30% |
Profit Margin | -17.93% | -21.29% | -27.15% | -26.98% | -59.63% | -54.56% |
Free Cash Flow Margin | 5.71% | -1.00% | 3.44% | 1.37% | -17.97% | -1.22% |
EBITDA | 0.16 | 0.1 | 0.05 | 0.1 | -0.25 | -0.37 |
EBITDA Margin | 8.23% | 5.21% | 3.45% | 6.91% | -20.04% | -26.38% |
D&A For EBITDA | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 |
EBIT | 0.09 | 0.03 | -0.01 | 0.04 | -0.31 | -0.44 |
EBIT Margin | 4.91% | 1.82% | -0.57% | 2.75% | -25.06% | -31.30% |